Coloured Ties Announces Approval of Option Agreement with Superior, Grant of Options and Closing of Substantial Issuer Bid

Investing News NetworkYour trusted source for investing success

tsxv pdp 2023

NASDAQ:DOVA
Pharmaceutical Investing

5 Top Pharmaceutical News Stories of 2018

TSXV:PDP
Pharmaceutical Investing

Pediapharm CEO Projects to Reach CA$35 Million in Revenue

MARKETS

Markets
TSX20714.48+13.98
TSXV622.01+0.87
DOW33978.08+28.67
S&P 5004070.56+10.13
NASD11621.71+109.30
ASX7493.80+25.50

COMMODITIES

Commodities
Gold1927.96+0.24
Silver23.60+0.01
Copper4.23-0.04
Palladium1713.170.00
Platinum1087.260.00
Oil79.38-1.63
Heating Oil3.19-0.11
Natural Gas2.85-0.09

DOWNLOAD FREE REPORTS

NEW! 2023 Critical Metals Outlook.

NEW! 2023 Agriculture Outlook Report

NEW! 2023 Rare Earths Outlook: Australia Edition

NEW! 2023 Zinc Outlook Report

NEW! 2023 Lithium Investor Report

Browse more resource reports ≫

NEW! 2023 Cleantech Outlook Report

Emerging Tech Outlook 2023

NEW! 2023 AI Outlook Report

NEW! 2023 Crypto Outlook Report

Start Here – Investing in Crypto

Browse more technology reports ≫

NEW! 2023 Pharmaceuticals Outlook Report.

FREE 2023 Psychedelics Investor Report

NEW! 2023 Biotech Outlook Report.

NEW! 2023 Life Science Outlook Report.

Start Here – Investing in Pharma

Browse more life science reports ≫

BROWSE COMPANIES BY SECTOR

loader